On the public citation graph
Genomic signatures to guide the use of chemotherapeutics
0 signed · 598 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Retraction Watch lists this work as retracted (export 2026-10-28; notice 2011-01-07, 10.1038/nm0111-135). OpenCitations Index CSV, figshare 24356626 v8 (2026-09-08) records 530 citing works; 159 have dates after the notice under the dataset’s date-resolution rule.
Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6openalex-snapshot
Reporting results of cancer treatment
inferredcites →https://doi.org/10.1002/ijc.21570openalex-snapshot
Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations
inferredcites →https://doi.org/10.1016/j.ccr.2005.03.002openalex-snapshot
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia
inferredcites →https://doi.org/10.1016/j.drup.2005.07.002openalex-snapshot
Anticancer therapeutics: “Addictive” targets, multi-targeted drugs, new drug combinations
inferredcites →https://doi.org/10.1016/s0140-6736(03)14023-8openalex-snapshot
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
inferredcites →https://doi.org/10.1038/nature04296openalex-snapshot
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
inferredcites →https://doi.org/10.1056/nejmoa033513openalex-snapshot
Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment
inferredcites →https://doi.org/10.1073/pnas.0408974102openalex-snapshot
Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer
inferredcites →https://doi.org/10.1073/pnas.191368598openalex-snapshot
Chemosensitivity prediction by transcriptional profiling
inferredcites →https://doi.org/10.1073/pnas.201162998openalex-snapshot
Predicting the clinical status of human breast cancer by using gene expression profiles
inferredcites →https://doi.org/10.1073/pnas.95.25.14863openalex-snapshot
Cluster analysis and display of genome-wide expression patterns
inferredcites →https://doi.org/10.1080/07357900500201301openalex-snapshot
Phosphorylated/Activated HER2 as a Marker of Clinical Resistance to Single Agent Taxane Chemotherapy for Metastatic Breast Cancer
inferredcites →https://doi.org/10.1080/10618600.1996.10474713openalex-snapshot
R: A Language for Data Analysis and Graphics
inferredcites →https://doi.org/10.1093/biostatistics/kxh011openalex-snapshot
Bayesian analysis of binary prediction tree models for retrospectively sampled outcomes
inferredcites →https://doi.org/10.1111/j.1365-2354.2006.00680.xopenalex-snapshot
Cancer: Principles and Practice of Oncology
inferredcites →https://doi.org/10.1126/science.1099578openalex-snapshot
A Bull's Eye for Targeted Lung Cancer Therapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-2421openalex-snapshot
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-05-0042openalex-snapshot
Association of Pretherapeutic Expression of Chemotherapy-Related Genes with Response to Neoadjuvant Chemotherapy in Barrett Carcinoma
inferredcites →https://doi.org/10.1158/1535-7163.mct-04-0282openalex-snapshot
Cyclin A–associated kinase activity is needed for paclitaxel sensitivity
inferredcites →https://doi.org/10.1186/bcr1323openalex-snapshot
Targeted therapy against Bcl-2-related proteins in breast cancer cells
inferredcites →https://doi.org/10.1200/jco.20.3.719openalex-snapshot
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2001.19.6.1734openalex-snapshot
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
inferredcites →https://doi.org/10.1200/jco.2002.20.3.719openalex-snapshot
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2005.01.112openalex-snapshot
Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment Trials
inferredcites →https://doi.org/10.1200/jco.2005.04.8678openalex-snapshot
Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
inferredcites →https://doi.org/10.4161/cc.4.12.2259openalex-snapshot
Why Therapeutic Response May Not Prolong the Life of a Cancer Patient: Selection for Oncogenic Resistance
inferredcites →https://doi.org/10.7326/0003-4819-114-9-819_4openalex-snapshot
Cancer: Principles and Practice of Oncology.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4648196openalex-extracted
The Digitalization of Science Computational Science as a Field of Inquiry in Design Science Research
inferred← citeshttps://doi.org/10.1001/jama.2008.638openalex-snapshot
Organizational Improvements to Enhance Modern Clinical Epidemiology
inferred← citeshttps://doi.org/10.1001/jama.2010.80openalex-snapshot
Age- and Sex-Specific Genomic Profiles in Non–Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1001/jama.2011.593openalex-snapshot
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
inferred← citeshttps://doi.org/10.1001/jama.299.13.1574openalex-snapshot
RETRACTED: Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer
inferred← citeshttps://doi.org/10.1002/9780470015902.a0022446openalex-snapshot
Molecular Genetics of Multiple Myeloma
inferred← citeshttps://doi.org/10.1002/9780470409770.ch1openalex-snapshot
Introduction: Genomics and Personalized Medicine
inferred← citeshttps://doi.org/10.1002/9780470475959.ch3openalex-snapshot
Molecular Pathology and Transcriptional Profiling in Early Drug Development
inferred← citeshttps://doi.org/10.1002/9780470524961.ch15openalex-snapshot
Pharmacogenomics of Dasatinib (Sprycel™)
inferred← citeshttps://doi.org/10.1002/9780470555293.ch11openalex-snapshot
Current Challenges and Future Directions
inferred← citeshttps://doi.org/10.1002/9780470571224.pse237openalex-snapshot
Biomarkers in Clinical Drug Development: Parallel Analysis of Alzheimer Disease and Multiple Sclerosis
inferred← citeshttps://doi.org/10.1002/9780470571224.pse285openalex-snapshot
Redefining Disease and Pharmaceutical Targets Through Molecular Definitions and Personalized Medicine
inferred← citeshttps://doi.org/10.1002/9780470696330.ch10openalex-snapshot
Molecular Profiling for Early Detection and Prediction of Response in Lung Cancer
inferred← citeshttps://doi.org/10.1002/9780470933947.ch9openalex-snapshot
Candidate Screening through Gene Expression Profile
inferred← citeshttps://doi.org/10.1002/9781118445112.stat06923.pub2openalex-snapshot
Clinical Trial Misconduct
inferred← citeshttps://doi.org/10.1002/9781118468791.ch31openalex-snapshot
Novel Clinical Trial Designs for Metastatic Lung Cancer
inferred← citeshttps://doi.org/10.1002/9783527848836.ch6openalex-snapshot
Toward a Blockchain‐Powered Anti‐Counterfeiting Experimental Data System in an Autonomous Laboratory
inferred← citeshttps://doi.org/10.1002/cncr.23644openalex-snapshot
Toward the individualization of lung cancer therapy
inferred← citeshttps://doi.org/10.1002/cncr.24350openalex-snapshot
Genomic approaches to outcome prediction in prostate cancer
inferred← citeshttps://doi.org/10.1002/dvdy.21381openalex-snapshot
Developmental signaling pathways in brain tumor‐derived stem‐like cells
inferred← citeshttps://doi.org/10.1002/emmm.201100187openalex-snapshot
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer
inferred← citeshttps://doi.org/10.1002/ijc.24782openalex-snapshot
Role of microRNA in anticancer drug resistance
inferred← citeshttps://doi.org/10.1002/ijc.25453openalex-snapshot
A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets
inferred← citeshttps://doi.org/10.1002/ijc.31158openalex-snapshot
Accurate prediction and elucidation of drug resistance based on the robust and reproducible chemoresponse communities
inferred← citeshttps://doi.org/10.1002/mc.20430openalex-snapshot
Gene expression profiling as a tool for basic analysis and clinical application of human cancer
inferred← citeshttps://doi.org/10.1002/path.2191openalex-snapshot
Predictive medicine: incipient reality or fata morgana?
inferred← citeshttps://doi.org/10.1002/path.2648openalex-snapshot
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
inferred← citeshttps://doi.org/10.1002/path.2951openalex-snapshot
Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target
inferred← citeshttps://doi.org/10.1002/pbc.21839openalex-snapshot
How do we identify novel treatment for childhood cancer?
inferred← citeshttps://doi.org/10.1002/prca.201300041openalex-snapshot
On best practices: The Institute of Medicine scheme for developing, validating, and demonstrating clinical utility of omics‐based diagnostic and predictive tests
inferred← citeshttps://doi.org/10.1002/sam.10046openalex-snapshot
Chemogenomics: Looking at biology through the lens of chemistry
inferred← citeshttps://doi.org/10.1002/sim.5405openalex-snapshot
Current development in clinical trials: issues old and new
inferred← citeshttps://doi.org/10.1002/wsbm.51openalex-snapshot
Systems approaches and algorithms for discovery of combinatorial therapies
inferred← citeshttps://doi.org/10.1007/978-0-387-73161-2_7openalex-snapshot
New Tools for Assessing Breast Cancer Recurrence
inferred← citeshttps://doi.org/10.1007/978-1-4419-0131-6_20openalex-snapshot
Gene Expression Microarrays in Cancer Research
inferred← citeshttps://doi.org/10.1007/978-1-4419-0769-1_10openalex-snapshot
Personalized Therapy for Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4419-0787-5_14openalex-snapshot
Molecular Pathology of Lung Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4419-7219-4_10openalex-snapshot
Immune Signatures and Systems Biology of Vaccines
inferred← citeshttps://doi.org/10.1007/978-1-4419-7358-0_9openalex-snapshot
Pharmacodynamic Studies in Early Phase Drug Development
inferred← citeshttps://doi.org/10.1007/978-1-4614-0323-4_10openalex-snapshot
Topoisomerase I Inhibitors: Chemical Biology
inferred← citeshttps://doi.org/10.1007/978-1-4939-2886-6_10openalex-snapshot
Molecular Classification of Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-3204-7_9openalex-snapshot
Cancer Gene Profiling for Response Prediction
inferred← citeshttps://doi.org/10.1007/978-1-59745-545-9_16openalex-snapshot
Cancer Gene Profiling for Response Prediction
inferred← citeshttps://doi.org/10.1007/978-1-60327-088-5_20openalex-snapshot
Toxicogenomics Application to Oncology Drug Development
inferred← citeshttps://doi.org/10.1007/978-1-60327-553-8_7openalex-snapshot
Modeling Astrocytomas in a Family of Inducible Genetically Engineered Mice: Implications for Preclinical Cancer Drug Development
inferred← citeshttps://doi.org/10.1007/978-1-60761-524-8_1openalex-snapshot
Molecular Pathology of Lung Cancer
inferred← citeshttps://doi.org/10.1007/978-1-60761-580-4_16openalex-snapshot
Multi-gene Expression-based Statistical Approaches to Predicting Patients’ Clinical Outcomes and Responses
inferred← citeshttps://doi.org/10.1007/978-1-60761-928-4_9openalex-snapshot
Molecular Nomograms for Predicting Prognosis and Treatment Response
inferred← citeshttps://doi.org/10.1007/978-1-61779-358-5_2openalex-snapshot
Heterogeneity of Breast Cancer: Gene Signatures and Beyond
inferred← citeshttps://doi.org/10.1007/978-1-61779-448-3_5openalex-snapshot
Gene Expression Profiling Using 3′ Tag Digital Approach
inferred← citeshttps://doi.org/10.1007/978-2-287-71478-8_27openalex-snapshot
Classification moléculaire des cancers du sein: vers une classification prédictive
inferred← citeshttps://doi.org/10.1007/978-3-030-26615-8_9openalex-snapshot
Health Effects of E-waste Pollution
inferred← citeshttps://doi.org/10.1007/978-3-030-63355-4_24openalex-snapshot
State of the Art in Artificial Intelligence and Machine Learning Techniques for Improving Patient Outcomes Pertaining to the Cardiovascular and Respiratory Systems
inferred← citeshttps://doi.org/10.1007/978-3-319-27347-1_12openalex-snapshot
Current Concepts of Pharmacogenetics, Pharmacogenomics, and the “Druggable” Genome
inferred← citeshttps://doi.org/10.1007/978-3-642-15865-0_16openalex-snapshot
A Conceptual Modeling Approach To Improve Human Genome Understanding
inferred← citeshttps://doi.org/10.1007/978-3-642-23957-1_50openalex-snapshot
Information-Preserving Techniques Improve Chemosensitivity Prediction of Tumours Based on Expression Profiles
inferred← citeshttps://doi.org/10.1007/978-3-642-41281-3_13openalex-snapshot
Computational Biomarker Discovery
inferred← citeshttps://doi.org/10.1007/978-3-7091-0144-5_15openalex-snapshot
Current concepts of pharmacogenetics, pharmacogenomics, and the “druggable” genome
inferred← citeshttps://doi.org/10.1007/978-90-481-2918-8_4openalex-snapshot
Subgroups of Ovarian Carinoma: Identification Using Differential Gene Expression
inferred← citeshttps://doi.org/10.1007/978-94-007-5842-1_10openalex-snapshot
Genomic Landscape of Ovarian Cancer
inferred← citeshttps://doi.org/10.1007/bf03256258openalex-snapshot
Genomic Signatures Associated with the Development, Progression, and Outcome of Prostate Cancer
inferred← citeshttps://doi.org/10.1007/s00200-012-0166-8openalex-snapshot
Topological analysis of gene expression arrays identifies high risk molecular subtypes in breast cancer
inferred← citeshttps://doi.org/10.1007/s00428-009-0774-2openalex-snapshot
Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers
inferred← citeshttps://doi.org/10.1007/s00761-010-1866-yopenalex-snapshot
Molekulare Marker zur Responseprädiktion beim lokal fortgeschrittenen Rektumkarzinom
inferred← citeshttps://doi.org/10.1007/s10049-011-1543-8openalex-snapshot
How journals can prevent, detect and respond to misconduct
inferred← citeshttps://doi.org/10.1007/s10304-009-0303-zopenalex-snapshot
Die Bedeutung von Mikroarrays für das Mammakarzinom
inferred← citeshttps://doi.org/10.1007/s10549-008-0017-2openalex-snapshot
Molecular profiles of progesterone receptor loss in human breast tumors
inferred← citeshttps://doi.org/10.1007/s10549-008-0183-2openalex-snapshot
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
inferred← citeshttps://doi.org/10.1007/s10549-009-0445-7openalex-snapshot
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines
inferred← citeshttps://doi.org/10.1007/s10549-010-0814-2openalex-snapshot
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
inferred← citeshttps://doi.org/10.1007/s10549-010-0985-xopenalex-snapshot
Re-searching anthracycline therapy
inferred← citeshttps://doi.org/10.1007/s10549-011-1626-8openalex-snapshot
A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity
inferred← citeshttps://doi.org/10.1007/s10549-011-1687-8openalex-snapshot
Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents
inferred← citeshttps://doi.org/10.1007/s10549-011-1891-6openalex-snapshot
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
inferred← citeshttps://doi.org/10.1007/s10555-014-9547-8openalex-snapshot
Proteomics of ovarian cancer: functional insights and clinical applications
inferred← citeshttps://doi.org/10.1007/s10555-016-9653-xopenalex-snapshot
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
inferred← citeshttps://doi.org/10.1007/s10585-007-9110-xopenalex-snapshot
Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis
inferred← citeshttps://doi.org/10.1007/s10585-012-9508-yopenalex-snapshot
Rigorous quantitative sciences integration—the foundation of high-dimensional genomic research
inferred← citeshttps://doi.org/10.1007/s10916-016-0678-zopenalex-snapshot
Building a Personalized Cancer Treatment System
inferred← citeshttps://doi.org/10.1007/s11154-007-9035-3openalex-snapshot
Molecular profiling in breast cancer
inferred← citeshttps://doi.org/10.1007/s11229-015-0744-yopenalex-snapshot
Error statistical modeling and inference: Where methodology meets ontology
inferred← citeshttps://doi.org/10.1007/s11523-008-0083-8openalex-snapshot
Pharmacogenetics in lung cancer for the lay doctor
inferred← citeshttps://doi.org/10.1007/s11864-008-0075-zopenalex-snapshot
Individualizing Chemotherapy for Non-small Cell Lung Cancer (NSCLC) in the Adjuvant and Advanced Setting: Current Status and Future Directions
inferred← citeshttps://doi.org/10.1007/s11888-007-0023-5openalex-snapshot
Adjuvant therapy for colon cancer based on pharmacogenomics?
inferred← citeshttps://doi.org/10.1007/s11912-009-0037-zopenalex-snapshot
Translating genomics into clinical practice: Applications in lung cancer
inferred← citeshttps://doi.org/10.1007/s12032-010-9443-1openalex-snapshot
Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s12609-009-0030-4openalex-snapshot
Advances in clinical trial designs for predictive biomarker discovery and validation
inferred← citeshttps://doi.org/10.1007/s12609-012-0094-4openalex-snapshot
The Future of Chemotherapy in the Era of Personalized Medicine
inferred← citeshttps://doi.org/10.1007/s13277-012-0558-1openalex-snapshot
Significant alterations in the expression pattern of kallikrein-related peptidase genes KLK4, KLK5 and KLK14 after treatment of breast cancer cells with the chemotherapeutic agents epirubicin, docetaxel and methotrexate
inferred← citeshttps://doi.org/10.1007/s15035-009-0150-3openalex-snapshot
Genexpressionsprofile in der onkologischen Diagnostik
inferred← citeshttps://doi.org/10.1016/b978-0-12-369420-1.00013-5openalex-snapshot
DNA Microarrays in Biological Discovery and Patient Care
inferred← citeshttps://doi.org/10.1016/b978-0-12-369420-1.00028-7openalex-snapshot
The Role of Genomics and Genetics in Drug Discovery and Development
inferred← citeshttps://doi.org/10.1016/b978-0-12-369420-1.00037-8openalex-snapshot
Public—Private Interactions in Genomic Medicine: Research and Development
inferred← citeshttps://doi.org/10.1016/b978-0-12-369420-1.00071-8openalex-snapshot
Genomics of Lung Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-369420-1.00072-xopenalex-snapshot
Breast Cancer and Genomic Medicine
inferred← citeshttps://doi.org/10.1016/b978-0-12-369420-1.00080-9openalex-snapshot
Molecular Therapeutics of Melanoma
inferred← citeshttps://doi.org/10.1016/b978-0-12-372550-9.00016-xopenalex-snapshot
Systems Pharmacology in Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-372550-9.00017-1openalex-snapshot
Systems Biology in Drug Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-12-374419-7.00025-1openalex-snapshot
Molecular Biology of Breast Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-374934-5.00001-5openalex-snapshot
The Foundations of Genomic and Personalized Medicine
inferred← citeshttps://doi.org/10.1016/b978-0-12-374934-5.00007-6openalex-snapshot
DNA Microarrays in Biological Discovery and Patient Care
inferred← citeshttps://doi.org/10.1016/b978-0-12-374934-5.00034-9openalex-snapshot
Genomics in the Diagnosis and Management of Lung Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-374934-5.00035-0openalex-snapshot
Genomics in the Diagnosis and Management of Breast Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-374934-5.00037-4openalex-snapshot
Genomic Evaluation and Management of Prostate Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-802761-5.00026-2openalex-snapshot
Molecular Biology of Breast Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-804725-5.00001-xopenalex-snapshot
Reproducibility in Biomedical Research
inferred← citeshttps://doi.org/10.1016/b978-0-323-95120-3.00004-xopenalex-snapshot
Role of pharmacogenomics for prediction of personalized medicines
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3291-5.50025-1openalex-snapshot
THERAPEUTIC drug MONITORING
inferred← citeshttps://doi.org/10.1016/b978-1-4160-5221-0.00025-5openalex-snapshot
Investigational Molecular Prognostic Factors for Breast Carcinoma
inferred← citeshttps://doi.org/10.1016/b978-1-84334-669-2.50014-7openalex-snapshot
Publishing ethics and integrity
inferred← citeshttps://doi.org/10.1016/j.addr.2015.10.019openalex-snapshot
“Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ajog.2010.02.003openalex-snapshot
Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin
inferred← citeshttps://doi.org/10.1016/j.annemergmed.2012.06.002openalex-snapshot
Go Back, Jack, and Do It Again
inferred← citeshttps://doi.org/10.1016/j.athoracsur.2007.11.047openalex-snapshot
Molecular Biologic Staging of Lung Cancer
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2015.05.012openalex-snapshot
Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.bcp.2007.10.016openalex-snapshot
Next generation topoisomerase I inhibitors: Rationale and biomarker strategies
inferred← citeshttps://doi.org/10.1016/j.bcp.2010.03.029openalex-snapshot
Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells
inferred← citeshttps://doi.org/10.1016/j.bcp.2013.08.026openalex-snapshot
Biomarkers in pharmacology and drug discovery
inferred← citeshttps://doi.org/10.1016/j.bdq.2015.01.002openalex-snapshot
The reproducibility of biomedical research: Sleepers awake!
inferred← citeshttps://doi.org/10.1016/j.berh.2024.102006openalex-snapshot
Explainable biology for improved therapies in precision medicine: AI is not enough
inferred← citeshttps://doi.org/10.1016/j.biocel.2007.03.011openalex-snapshot
The new frontier in cancer research: Deciphering cancer epigenetics
inferred← citeshttps://doi.org/10.1016/j.biocel.2009.12.017openalex-snapshot
Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications
inferred← citeshttps://doi.org/10.1016/j.breast.2007.07.032openalex-snapshot
The evolution of treatment strategies: Aiming at the target
inferred← citeshttps://doi.org/10.1016/j.burns.2026.108020openalex-snapshot
Variation in standards for reporting artificial intelligence research using burn image datasets raises ethical questions: A scoping review
inferred← citeshttps://doi.org/10.1016/j.ccr.2007.04.011openalex-snapshot
Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs
inferred← citeshttps://doi.org/10.1016/j.cell.2010.02.011openalex-snapshot
Protein Dynamics in Drug Combinations: a Linear Superposition of Individual-Drug Responses
inferred← citeshttps://doi.org/10.1016/j.cellsig.2010.05.006openalex-snapshot
PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells
inferred← citeshttps://doi.org/10.1016/j.clim.2008.09.001openalex-snapshot
Translation of genomics research at the bedside: The promise and the challenge
inferred← citeshttps://doi.org/10.1016/j.coph.2008.08.003openalex-snapshot
Use of ex vivo systems for biomarker discovery
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2011.03.006openalex-snapshot
Genomic analysis: Toward a new approach in breast cancer management
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2011.05.005openalex-snapshot
Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2012.08.003openalex-snapshot
Molecular biology in breast cancer: Should molecular classifiers be assessed by conventional tools or by gene expression arrays?
inferred← citeshttps://doi.org/10.1016/j.ctrv.2007.07.013openalex-snapshot
A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship
inferred← citeshttps://doi.org/10.1016/j.ctrv.2010.01.001openalex-snapshot
Localized adenocarcinoma of the esophagogastric junction – Is there a standard of care?
inferred← citeshttps://doi.org/10.1016/j.ddstr.2010.02.001openalex-snapshot
Can phenotypic pathway signatures improve the prediction of response to PI3K pathway inhibitors?
inferred← citeshttps://doi.org/10.1016/j.drudis.2008.03.003openalex-snapshot
The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine
inferred← citeshttps://doi.org/10.1016/j.drudis.2023.103761openalex-snapshot
Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy
inferred← citeshttps://doi.org/10.1016/j.drup.2009.07.001openalex-snapshot
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
inferred← citeshttps://doi.org/10.1016/j.drup.2010.10.001openalex-snapshot
Parameters for individualizing systemic therapy in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.dss.2024.114368openalex-snapshot
Digitalization of the natural sciences: Design science research and computational science
inferred← citeshttps://doi.org/10.1016/j.ejca.2007.01.004openalex-snapshot
Prognostic molecular markers in hepatocellular carcinoma: A systematic review
inferred← citeshttps://doi.org/10.1016/j.ejca.2009.01.004openalex-snapshot
Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial
inferred← citeshttps://doi.org/10.1016/j.ejca.2009.04.036openalex-snapshot
Predictive signatures for chemotherapy sensitivity in breast cancer: Are they ready for use in the clinic?
inferred← citeshttps://doi.org/10.1016/j.exphem.2009.09.009openalex-snapshot
Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation
inferred← citeshttps://doi.org/10.1016/j.gde.2008.01.018openalex-snapshot
Utilization of genomic signatures to direct use of primary chemotherapy
inferred← citeshttps://doi.org/10.1016/j.gyobfe.2010.05.004openalex-snapshot
Prédicteurs clinicopathologiques et génomiques de la réponse à la chimiothérapie néoadjuvante dans les cancers du sein
inferred← citeshttps://doi.org/10.1016/j.humpath.2008.04.020openalex-snapshot
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.jamcollsurg.2008.03.003openalex-snapshot
Molecular Mechanisms for Individualized Cancer Care
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2013.11.002openalex-snapshot
Assessing and Comparing the Performance of Molecular Diagnostic Tests
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2014.09.002openalex-snapshot
Regulating Laboratory-Developed Tests
inferred← citeshttps://doi.org/10.1016/j.jpba.2014.10.018openalex-snapshot
A transcription/translation-based gene signature predicts resistance to chemotherapy in breast cancer
inferred← citeshttps://doi.org/10.1016/j.jtbi.2010.05.019openalex-snapshot
An advanced discrete state–discrete event multiscale simulation model of the response of a solid tumor to chemotherapy: Mimicking a clinical study
inferred← citeshttps://doi.org/10.1016/j.leukres.2011.06.019openalex-snapshot
Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia
inferred← citeshttps://doi.org/10.1016/j.lungcan.2010.07.016openalex-snapshot
Bronchoscopic Microsampling is a Useful Complementary Diagnostic Tool for Detecting Lung Cancer
inferred← citeshttps://doi.org/10.1016/j.molonc.2007.02.004openalex-snapshot
The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression
inferred← citeshttps://doi.org/10.1016/j.molonc.2010.04.004openalex-snapshot
Histological types of breast cancer: How special are they?
inferred← citeshttps://doi.org/10.1016/j.molonc.2010.04.005openalex-snapshot
Molecular basis for therapy resistance
inferred← citeshttps://doi.org/10.1016/j.ncl.2007.07.004openalex-snapshot
Diagnosis and Treatment of High-Grade Astrocytoma
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2010.04.012openalex-snapshot
A survey of yeast genomic assays for drug and target discovery
inferred← citeshttps://doi.org/10.1016/j.psc.2010.11.005openalex-snapshot
Genomics for Disease Treatment and Prevention
inferred← citeshttps://doi.org/10.1016/j.semcancer.2008.03.013openalex-snapshot
Unraveling the microenvironmental influences on the normal mammary gland and induction and progression of breast cancer
inferred← citeshttps://doi.org/10.1016/j.semcancer.2012.02.011openalex-snapshot
Gene expression profiling to dissect the complexity of cancer biology: Pitfalls and promise
inferred← citeshttps://doi.org/10.1016/j.semradonc.2007.10.007openalex-snapshot
Using Microarray Analysis as a Prognostic and Predictive Tool in Oncology: Focus on Breast Cancer and Normal Tissue Toxicity
inferred← citeshttps://doi.org/10.1016/j.shpsc.2011.10.004openalex-snapshot
Too many numbers: Microarrays in clinical cancer research
inferred← citeshttps://doi.org/10.1016/j.suronc.2013.10.001openalex-snapshot
Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.thorsurg.2008.07.001openalex-snapshot
Detection of Occult N2 Disease with Molecular Techniques
inferred← citeshttps://doi.org/10.1016/j.tibtech.2007.08.005openalex-snapshot
Ecotoxicological risk assessment using DNA chips and cellular reporters
inferred← citeshttps://doi.org/10.1016/j.trsl.2009.09.005openalex-snapshot
Genomic and personalized medicine: foundations and applications
inferred← citeshttps://doi.org/10.1016/j.yasu.2008.04.003openalex-snapshot
Neoadjuvant Therapy for Gastric Cancer
inferred← citeshttps://doi.org/10.1016/j.ygyno.2008.08.017openalex-snapshot
Role of microRNAs in drug-resistant ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.ygyno.2009.01.014openalex-snapshot
MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy
inferred← citeshttps://doi.org/10.1016/j.ygyno.2010.11.017openalex-snapshot
Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells
inferred← citeshttps://doi.org/10.1016/j.ygyno.2011.09.020openalex-snapshot
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin
inferred← citeshttps://doi.org/10.1016/j.ymeth.2012.05.005openalex-snapshot
The challenge of gene expression profiling in heterogeneous clinical samples
inferred← citeshttps://doi.org/10.1016/s0031-3025(16)33092-6openalex-snapshot
Molecular classification of breast cancer
inferred← citeshttps://doi.org/10.1016/s0093-3619(08)70658-0openalex-snapshot
Genomic signatures to guide the use of chemotherapeutics
inferred← citeshttps://doi.org/10.1016/s0104-4230(11)70071-9openalex-snapshot
Transcriptional profile and response to neoadjuvant chemotherapy in breast cancer
inferred← citeshttps://doi.org/10.1016/s0140-6736(11)61539-0openalex-snapshot
Gene expression profiling in breast cancer: classification, prognostication, and prediction
inferred← citeshttps://doi.org/10.1016/s0761-8417(09)73436-4openalex-snapshot
Quoi de neuf dans les facteurs biologiques prédictifs de l’efficacité de la chimiothérapie ?
inferred← citeshttps://doi.org/10.1016/s0960-9776(09)70268-1openalex-snapshot
Aiming at the target: improved adjuvant medical therapy
inferred← citeshttps://doi.org/10.1016/s1028-4559(08)60024-8openalex-snapshot
Microarray Analysis of Gene Expression of Cancer to Guide the Use of Chemotherapeutics
inferred← citeshttps://doi.org/10.1016/s1359-6349(07)70029-0openalex-snapshot
When should I start using a new biomarker: Focus on expression arrays?
inferred← citeshttps://doi.org/10.1016/s1359-6349(07)70031-9openalex-snapshot
Finding biomarkers of resistance to targeted cancer therapies
inferred← citeshttps://doi.org/10.1016/s1470-2045(07)70345-5openalex-snapshot
RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
inferred← citeshttps://doi.org/10.1016/s1470-2045(09)70155-xopenalex-snapshot
Molecular predictive and prognostic markers in non-small-cell lung cancer
inferred← citeshttps://doi.org/10.1016/s1470-2045(11)70011-0openalex-snapshot
Retraction—validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
showing the first 200 of 571 · page through all 571
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.